FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.05-4863fje.
This Article
Right arrow Summary
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
fj.05-4863fjev1
20/7/950    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ishikawa, F.
Right arrow Articles by Harada, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishikawa, F.
Right arrow Articles by Harada, M.
(The FASEB Journal. 2006;20:950-952.)
© 2006 FASEB

Purified human hematopoietic stem cells contribute to the generation of cardiomyocytes through cell fusion

Fumihiko Ishikawa*,1,2, Hideki Shimazu*,1, Leonard D. Shultz||, Mitsuhiro Fukata*, Ryu Nakamura{ddagger}, Bonnie Lyons||, Kazuya Shimoda*, Shinji Shimoda*, Takaaki Kanemaru*, Kei-ichiro Nakamura{dagger}, Hiroyuki Ito*, Yoshikazu Kaji*, Anthony C.F. Perry§ and Mine Harada*

* Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan;

{dagger} Second Department of Anatomy, Kurume University School of Medicine, Kurume, Japan;

{ddagger} Zeiss Japan, Tokyo, Japan;

§ Laboratory of Mammalian Molecular Embryology, RIKEN Center for Developmental Biology, Kobe, Japan;

|| The Jackson Laboratory, Bar Harbor, Maine; and

Research Unit for Human Disease Model, RIKEN Center for Allergy and Immunology, Yokohama, Japan

2Correspondence: Kyushu University Graduate School of Medical Sciences, Department of Medicine and Biosystemic Science, 3–1-1 Maidashi, Higashi-ku, Fukuoka 812-8582. E-mail: f_ishika{at}intmed1.med.kyushu-u.ac.jp

ABSTRACT

To obtain insights into the cardiomyogenic potential of hematopoietic tissue, we intravenously (i.v.) injected purified hematopoietic stem/progenitor cells into newborn recipients that may fully potentiate the developmental plasticity of stem cells. Transplantation of mouse bone marrow (BM) lineage antigen-negative (Lin) cells resulted in the generation of the cells that displayed cardiomyocyte-specific antigenic profiles and contractile function when transplanted into syngeneic newborn recipients. To clarify the mechanism underlying the cardiomyogenic potential, green fluorescent protein (GFP)-labeled BM LinScaI+ hematopoietic progenitors were transplanted into neonatal mice constitutively expressing cyan fluorescence protein (CFP). Lambda image acquisition and linear unmixing analysis using confocal microscopy successfully separated GFP and CFP, and revealed that donor GFP+ cardiomyocytes coexpressed host-derived CFP. We further reconstituted human hemopoietic- and immune systems in mice by injecting human cord blood (CB)-derived LinCD34+CD38 hematopoietic stem cells (HSCs) into neonatal T cellB cellNK cell immune-deficient NOD/SCID/IL2r{gamma}null mice. Fluoroescence in situ hybridization analysis of recipient cardiac tissues demonstrated that human and murine chromosomes were colocalized in the same cardiomyocytes, indicating that cell fusion occurred between human hematopoietic progeny and mouse cardiomyocytes. These syngeneic- and xenogeneic neonatal transplantations provide compelling evidence that hematopoietic stem/progenitor cells contribute to the postnatal generation of cardiomyocytes through cell fusion, not through transdifferentiation.— Ishikawa, F., Shimazu, H., Shultz, L. D., Fukata, M., Nakamura, R., Lyons, B., Shimoda, K., Shimoda, S., Kanemaru, T., Nakamura, K-i., Ito, H., Kaji, Y., Perry, A. C. F., Harada, M. Purified human hematopoietic stem cells contribute to the generation of cardiomyocytes through cell fusion.




This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. M. Majka, M. Skokan, L. Wheeler, J. Harral, S. Gladson, E. Burnham, J. E. Loyd, K. R. Stenmark, M. Varella-Garcia, and J. West
Evidence for cell fusion is absent in vascular lesions associated with pulmonary arterial hypertension
Am J Physiol Lung Cell Mol Physiol, December 1, 2008; 295(6): L1028 - L1039.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Orlandi, F. Pagani, D. Avitabile, G. Bonanno, G. Scambia, E. Vigna, F. Grassi, F. Eusebi, S. Fucile, M. Pesce, et al.
Functional properties of cells obtained from human cord blood CD34+ stem cells and mouse cardiac myocytes in coculture
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1541 - H1549.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Miyata, M. Masuya, S. Yoshida, S. Nakamura, K. Kato, Y. Sugimoto, T. Shibasaki, K. Yamamura, K. Ohishi, K. Nishii, et al.
Hematopoietic origin of hepatic stellate cells in the adult liver
Blood, February 15, 2008; 111(4): 2427 - 2435.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. Dedja, T. Zaglia, L. Dall'Olmo, T. Chioato, G. Thiene, L. Fabris, E. Ancona, S. Schiaffino, S. Ausoni, and E. Cozzi
Hybrid cardiomyocytes derived by cell fusion in heterotopic cardiac xenografts
FASEB J, December 1, 2006; 20(14): 2534 - 2536.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by The Federation of American Societies for Experimental Biology.